81 related articles for article (PubMed ID: 15332767)
21. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
Kudoh T; Nagawaga T; Nakagawa I
Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
[TBL] [Abstract][Full Text] [Related]
22. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
23. Improvement of blood pressure control in hypertensive patients with renal diseases.
Ohta Y; Tsuruya K; Fujii K; Tokumoto M; Kanai H; Matsumura K; Tsuchihashi T; Hirakata H; Iida M
Hypertens Res; 2007 Apr; 30(4):295-300. PubMed ID: 17541207
[TBL] [Abstract][Full Text] [Related]
24. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
25. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
26. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ
J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
[TBL] [Abstract][Full Text] [Related]
27. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
28. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
29. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
30. [Calcium channel blocker for protection against hypertensive target-organ damage].
Fukuzawa J; Yao N; Sakuragi H; Baljinnyam E; Haneda T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():559-63. PubMed ID: 15171435
[No Abstract] [Full Text] [Related]
31. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
Zheng S; Nath V; Coyne DW
Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
[TBL] [Abstract][Full Text] [Related]
32. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure.
Afshinnia F; Spitalewitz S; Chou SY; Gunsburg DZ; Chadow HL
Am J Kidney Dis; 2007 Feb; 49(2):227-36. PubMed ID: 17261425
[TBL] [Abstract][Full Text] [Related]
34. Relationship between insulin resistance and end-organ damage in white coat hypertension.
Tunçkale A; Aran SN; Karpuz H; Dirican A
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1011-6. PubMed ID: 15533726
[TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
[TBL] [Abstract][Full Text] [Related]
36. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
Gu Q; Burt VL; Paulose-Ram R; Dillon CF
Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
[TBL] [Abstract][Full Text] [Related]
37. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
Ogihara T; Saruta T; Rakugi H; Shimamoto K; Ito S; Matsuoka H; Horiuchi M; Imaizumi T; Takishita S; Higaki J; Katayama S; Saito I; Shimada K;
Hypertens Res; 2009 Feb; 32(2):163-7. PubMed ID: 19262477
[TBL] [Abstract][Full Text] [Related]
38. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
Bangalore S; Messerli FH
Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591
[TBL] [Abstract][Full Text] [Related]
39. Management of hypertension in chronic kidney disease: the Italian multicentric study.
De Nicola L; Minutolo R; Gallo C; Zoccali C; Cianciaruso B; Conte M; Lupo A; Fuiano G; Gallucci M; Bonomini M; Chiodini P; Signoriello G; Bellizzi V; Mallamaci F; Nappi F; Conte G
J Nephrol; 2005; 18(4):397-404. PubMed ID: 16245243
[TBL] [Abstract][Full Text] [Related]
40. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
